Arterra Bioscience S.p.A. (BIT:ARBS)

Arterra Bioscience Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.34	3.34	3.69	4.39	4.81
Short-Term Investments	-	-	-	1.6	-
Cash & Short-Term Investments	1.34	3.34	3.69	5.99	4.81
Cash Growth	-59.84%	-9.29%	-38.48%	24.46%	6.13%
Accounts Receivable	-	-	0.69	-	0.81
Other Receivables	-	-	2.15	-	2.38
Total Trade Receivables	-	-	2.84	-	3.19
Inventory	1.54	1.33	1.36	1.16	0.49
Total Current Assets	6.88	8.29	7.89	9.81	8.49
Net Property, Plant & Equipment	-	-	1.23	1.54	1.66
Other Intangible Assets	-	-	0.04	0.2	0.44
Long-Term Investments	5.92	3.45	3.35	0.98	0.95
Other Long-Term Assets	0.09	0.11	0.04	0.04	0.04
Total Assets	14.59	13.4	12.55	12.57	11.58

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.48	0.55	0.5	0.19	0.25
Accrued Expenses	0.73	0.82	0.82	0.79	0.76
Short-Term Debt	-	-	-	0.03	0.07
Current Portion of Long-Term Debt	0.09	0.1	0.09	0.14	0.15
Total Current Liabilities	1.3	1.46	1.41	1.16	1.23
Long-Term Debt	0.43	0.62	0.69	0.32	0.39
Other Long-Term Liabilities	0.96	0.89	0.66	0.63	0.49
Total Long-Term Liabilities	1.38	1.51	1.35	0.95	0.88
Total Liabilities	2.69	2.98	2.76	2.1	2.11

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.33	0.33	0.33	0.33	0.33
Treasury Stock	-0.33	-0.33	-0.33	-0.2	-
Additional Paid-in Capital	4.17	4.17	4.17	4.17	4.17
Retained Earnings	7.34	7.25	6.58	6.17	4.86
Shareholders' Equity	11.51	11.42	10.75	10.47	9.47
Total Liabilities & Equity	14.59	13.4	12.55	12.57	11.58

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.52	0.71	0.77	0.49	0.61
Net Cash (Debt)	0.82	2.63	2.91	5.5	4.2
Net Cash Growth	-68.75%	-9.72%	-47.04%	31.02%	12.69%
Net Cash Per Share	0.12	0.40	0.44	0.83	0.63
Book Value	11.51	11.42	10.75	10.47	9.47
Book Value Per Share	1.73	1.72	1.61	1.57	1.42
Tangible Book Value	11.51	11.42	10.71	10.26	9.03
Tangible Book Value Per Share	1.73	1.72	1.61	1.54	1.36

Data Source: Fiscal.ai Last updated: Feb 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 26, 2026

Data Sources Report a data error